Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Finished Goods (2013 - 2015)

Iradimed (IRMD) reported Finished Goods of $292757.0 for Q3 2015, up 140.92% year-over-year from $121515.0 in Q3 2014, and down 31.96% on a QoQ basis from $430242.0 in Q2 2015.

Iradimed (IRMD) has 3 years of Finished Goods data on file, last reported at $292757.0 in Q3 2015.

  • Quarterly Finished Goods rose 140.92% year-over-year to $292757.0 in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $292757.0 (up 140.92% YoY) and the FY2014 annual result came in at $457962.0, up 150.94% from the prior year.
  • Finished Goods fell to $292757.0 in Q3 2015 per IRMD's latest filing, from $430242.0 in the prior quarter.
  • Across five years, Finished Goods topped out at $457962.0 in Q4 2014 and bottomed at $121515.0 in Q3 2014.
  • The 3-year median for Finished Goods is $292757.0 (2015), against an average of $299175.6.
  • The widest annual swing landed in 2014, when Finished Goods soared 150.94%; it then surged 103.44% in 2015.
  • Tracing IRMD's Finished Goods over 3 years: stood at $182499.0 in 2013, then soared by 150.94% to $457962.0 in 2014, then sank by 36.07% to $292757.0 in 2015.
  • Per Business Quant, the three latest IRMD Finished Goods figures stand at $292757.0 (Q3 2015), $430242.0 (Q2 2015), and $397768.0 (Q1 2015).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Iradimed 1.17 Bn 1.11 Bn 16.81 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2015 292,757.00
Jun 30, 2015 430,242.00
Mar 31, 2015 397,768.00
Dec 31, 2014 457,962.00
Sep 30, 2014 121,515.00
Jun 30, 2014 211,486.00
Dec 31, 2013 182,499.00